{
  "trial_id": "NCT03261466",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "homogeneous for number and sex of the subjects",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "randomization in a 1:1 to probiotic intervention group or placebo group",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "standard diet with 55-60% of carbohydrates, 25-30% lipids and 15% proteins",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "physical activity: 30 minutes of aerobic physical activity daily",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "evaluation at time of enrollment (V0) and, at the end of the first part of study (Study 1, V1)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "biochemical evaluations after a 12-h overnight fast",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ultrasound evaluations and questionnaires",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "cross-over study (study 2, V2-V3) after one month of wash-out",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "patients will be evaluated at V2 and, after 2 months of treatment (Study 2, V3)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "anthropometric measures: height, weight, body mass index (BMI), waist and hip circumferences",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "blood pressure and heart rate",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "biochemical evaluations: CBC with formula, serum insulin-like growth factor 1 (IGF1), 25-hydroxy (OH) vitamin D, uric acid, alkaline phosphatase, ACTH, cortisol, TSH, fT4",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "serum creatinine concentration and eGFR calculation using updated Schwartz's formula",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Adverse reactions to the product or component of the product (allergies\u2026)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Genetic obesity (Prader Willi syndrome, Down syndrome), Metabolic obesity (Laurence-biedl syndrome\u2026), endocrinological obesity (Cushinch syndrome, hypotiroidism)",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Chronic diseases, hepatic or gastroenterological diseases",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Medical treatment for chronic diseases",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Probiotic or prebiotic therapies and antibiotic treatment",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has Wegener's granulomatosis, but is currently being treated with corticosteroid and cyclophosphamides. He also has a high Birmingham Vasculitis Activity Score (BVAS) above 4.",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT03261466",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}